Skip to main content
Year archive

CStone Pharmaceuticals — 2023 filings

All 236 regulatory filings released by CStone Pharmaceuticals (2616) in 2023, sourced directly from the official regulator.

236 Filings
2023 Period
2023 filings (236)
Filing Released Lang
FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2023-12-28 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2023-12-28 English
(1) PROPOSED GRANT OF OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP&#x3b; (2) NOTICE OF EXTRAORDINARY GENERAL MEETING&#x3b; AND (3) CLOSURE OF REGISTER OF MEMBERS FOR THE E
Proxy Solicitation & Information Statement
2023-12-28 English
BOOK CLOSURE PERIOD FOR EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2023-12-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-12-22 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE ASSET PURCHASE AGREEMENT
Capital/Financing Update
2023-12-21 English
INSIDE INFORMATION ANNOUNCEMENT - LATEST BUSINESS UPDATE
Investor Presentation
2023-12-20 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES INCLUSION OF AYVAKIT (AVAPRITINIB) IN 2023 CHINA'S NATIONAL REIMBURSEMENT DRUG LIST
Regulatory Filings
2023-12-13 English
Announcement on Confirmation of Transaction of Bidding for Detailed Exploration Rights of Coal Resources
Capital/Financing Update
2023-12-08 English
CONTINUING CONNECTED TRANSACTIONS-THE 2024 DIESEL FUEL SUPPLY AGREEMENT
Regulatory Filings
2023-12-08 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL OF SUGEMALIMAB AS FIRST-LINE TREATMENT FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Regulatory Filings
2023-12-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Share Issue/Capital Change
2023-12-06 English
Monthly Returns
Share Issue/Capital Change
2023-12-04 English
ANNOUNCEMENT ON THE PLAN TO INCREASE SHAREHOLDING IN THE COMPANY BY THE CONTROLLING SHAREHOLDER
Major Shareholding Notification
2023-11-29 English
Next Day Disclosure Return
Share Issue/Capital Change
2023-11-17 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-11-13 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-11-13 English
GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
Capital/Financing Update
2023-11-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023
Share Issue/Capital Change
2023-11-06 English
ANNOUNCEMENT ON PROGRESS UPDATE OF THE DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ABSORPTION AND MERGER&#x3b;AND SUPPLEMENTAL INFORMATION ON CONNECTED TRANSACTION IN RELATION TO THE ACQ
Capital/Financing Update
2023-11-06 English
Monthly Returns
Regulatory Filings
2023-11-03 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES STRATEGIC PARTNERSHIP AND EXCLUSIVE LICENSING AGREEMENT WITH 3SBIO FOR NOFAZINLIMAB (ANTI-PD-1 ANTIBODY) IN MAINLAND CHINA
Capital/Financing Update
2023-11-01 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NMPA APPROVAL OF SUGEMALIMAB FOR PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA, THE FIRST ANTI-PD-1/PD-L1 MAB APPROVED FOR THIS
Regulatory Filings
2023-10-31 English
CONNECTED TRANSACTION ACQUISITION OF 100% EQUITY INTEREST IN COAL CHEMICAL ENGINEERING COMPANY
Merger & Acquisition
2023-10-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-27 English
RESULTS REPORT FOR THE THIRD QUARTER OF 2023
Interim / Quarterly Report Q3 2023
2023-10-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-27 English
ARTICLES OF ASSOCIATION OF YANKUANG ENERGY GROUP COMPANY LIMITED
Governance Information
2023-10-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-27 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2023 FIRST EXTRAORDINARY GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2023-10-27 English
OVERSEAS REGULATORY ANNOUNCEMENT NOTICE OF RESULTS PRESENTATION FOR THE THIRD QUARTER OF 2023
Investor Presentation
2023-10-25 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2023 FIRST TRANCHE OF MEDIUM-TERM NOTES
Capital/Financing Update
2023-10-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE SHOWCASED, IN AN ORAL SESSION, LATE-BREAKING RESULTS FROM PHASE 3 STUDY OF SUGEMALIMAB IN FIRST-LINE GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AT ESMO 2023
Regulatory Filings
2023-10-24 English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE THIRD QUARTER OF 2023
Regulatory Filings
2023-10-19 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE THIRD QUARTER OF 2023 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2023-10-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-19 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-10-13 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-10-13 English
Monthly Returns
Regulatory Filings
2023-10-08 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
Share Issue/Capital Change
2023-10-05 English
COMPLETION OF DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN TARGET COMPANIES
Capital/Financing Update
2023-10-03 English
VOLUNTARY ANNOUNCEMENT - INTENTION OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR TO INCREASE SHAREHOLDING IN THE COMPANY
Director's Dealing
2023-10-03 English
Documents on Display
Regulatory Filings
2023-09-28 English
Circular
Proxy Solicitation & Information Statement
2023-09-28 English
Circular
Proxy Solicitation & Information Statement
2023-09-28 English
Form of Proxy for Use at the 2023 First Extraordinary General Meeting to be Held on Friday, 27 October 2023
Proxy Solicitation & Information Statement
2023-09-28 English
NOTICE OF 2023 FIRST EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2023-09-28 English
NOTIFICATION LETTER
Report Publication Announcement
2023-09-28 English
INTERIM REPORT 2023
Interim / Quarterly Report H1 2023
2023-09-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-09-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Share Issue/Capital Change
2023-09-06 English
NOTIFICATION LETTER
Report Publication Announcement
2023-09-01 English
Monthly Returns
Share Issue/Capital Change
2023-09-01 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES REGISTRATIONAL TRIAL OF SUGEMALIMAB IN FIRST-LINE GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA MET PRIMARY ENDPOINT OF OVERALL SURVIVAL
Capital/Financing Update
2023-08-29 English
REVISION OF ANNUAL CAPS UNDER EXISTING BULK COMMODITIES SALE AND PURCHASE AGREEMENT&#x3b; AND RENEWAL OF CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
PROPOSED AMENDMENT TO THE ARTICLES OF ASSOCIATION
Governance Information
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
The Detailed Working Rules for the Sustainable Development Committee of the Board of Directors of Yankuang Energy Group Company Limited
Governance Information
2023-08-25 English
The Detailed Working Rules for the Remuneration Committee of the Board of Directors of Yankuang Energy Group Company Limited
Remuneration Information
2023-08-25 English
ANNOUNCEMENT ON INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report H1 2023
2023-08-25 English
Interim Report 2023
Interim / Quarterly Report H1 2023
2023-08-25 English
The Detailed Working Rules for the Audit Committee of the Board of Directors of Yankuang Energy Group Company Limited
Governance Information
2023-08-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-25 English
OVERSEAS REGULATORY ANNOUNCEMENT NOTICE OF 2023 INTERIM RESULTS PRESENTATION
Regulatory Filings
2023-08-23 English
PUBLICATION OF THE 2023 INTERIM RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2023-08-16 Yoruba
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
Interim / Quarterly Report H1 2023
2023-08-15 English
NOTICE OF BOARD MEETING
Report Publication Announcement
2023-08-11 English
Next Day Disclosure Return
Share Issue/Capital Change
2023-08-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
Share Issue/Capital Change
2023-08-04 English
Monthly Returns
Regulatory Filings
2023-08-04 English
DATE OF BOARD MEETING
Report Publication Announcement
2023-08-03 English
Rules of Procedure for Supervisory Committee of Yankuang Energy Group Company Limited
Governance Information
2023-08-01 English
Rules of Procedures for Shareholders General Meeting of Yankuang Energy Group Company Limited
Governance Information
2023-08-01 English
Rules of Procedures for the Board of Directors of Yankuang Energy Group Company Limited
Governance Information
2023-08-01 English
ARTICLES OF ASSOCIATION OF YANKUANG ENERGY GROUP COMPANY LIMITED
Governance Information
2023-08-01 English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE SECOND QUARTER OF 2023
Regulatory Filings
2023-07-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-07-19 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE SECOND QUARTER OF 2023 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2023-07-19 English
THIRD ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Regulatory Filings
2023-07-16 Yoruba
Next Day Disclosure Return
Share Issue/Capital Change
2023-07-16 English
SECOND ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Capital/Financing Update
2023-07-14 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES RECEIPT OF GCP INSPECTION NOTIFICATION FROM THE EUROPEAN MEDICINES AGENCY FOR SUGEMALIMAB MARKETING AUTHORIZATION APPLICATION
Regulatory Filings
2023-07-11 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-07-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
Regulatory Filings
2023-07-06 English
Monthly Returns
Regulatory Filings
2023-07-05 English
Final Dividend for the Year Ended 31 December 2022(Update)
Notice of Dividend Amount
2023-07-03 English
Special Dividend for the Year Ended 31 December 2022(Update)
Notice of Dividend Amount
2023-07-03 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2023 FIRST CLASS MEETING OF THE HOLDERS OF A SHARES AND THE RESOLUTIONS PASSED AT THE 2023 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 English
ANNOUNCEMENT IN RELATION TO THE RESOLUTIONS PASSED AT THE 2022 ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2023-06-30 English
ANNOUNCEMENT TO CREDITORS OF THE COMPANY IN RELATION TO GENERAL MANDATE GRANTED TO THE BOARD TO REPURCHASE H SHARES OF THE COMPANY
Capital/Financing Update
2023-06-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-30 English
Bonus Issue for the Year Ended 31 December 2022(Update)
Share Issue/Capital Change
2023-06-30 English
Special Dividend for the Year Ended 31 December 2022(Update)
Notice of Dividend Amount
2023-06-30 English
Final Dividend for the Year Ended 31 December 2022(Update)
Notice of Dividend Amount
2023-06-30 English
VOLUNTARY ANNOUNCEMENT - CSTONE PRESENTS RESULTS FROM PHASE 3 STUDY OF SUGEMALIMAB IN FIRST-LINE ESOPHAGEAL SQUAMOUS CELL CARCINOMA AT ESMO GI 2023
Regulatory Filings
2023-06-30 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES GAVRETO (PRALSETINIB) SNDA APPROVAL BY CHINA NMPA FOR FIRST-LINE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC RET FUSION-POSITIVE NON-SMALL CELL
Regulatory Filings
2023-06-27 English
VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 460,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 3,732,500 SHARES
Director's Dealing
2023-06-26 English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2023-06-21 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 21, 2023 AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Declaration of Voting Results & Voting Rights Announcements
2023-06-21 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-06-20 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2023 FIRST TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update
2023-06-19 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PUBLICATION IN NATURE CANCER HIGHLIGHTING THE OVERALL SURVIVAL RESULTS OF SUGEMALIMAB IN NON-SMALL CELL LUNG CANCER
Regulatory Filings
2023-06-16 English
OVERSEAS REGULATORY ANNOUNCEMENT
Regulatory Filings
2023-06-15 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES ORAL PRESENTATION AT ESMO WORLD GI 2023 FOR PIVOTAL PHASE 3 CLINICAL STUDY OF SUGEMALIMAB IN FIRST-LINE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Regulatory Filings
2023-06-13 English
Documents on Display
M&A Activity
2023-06-09 English
NOTIFICATION LETTER
Report Publication Announcement
2023-06-09 English
Circular
AGM Information
2023-06-09 English
VOLUNTARY ANNOUNCEMENT - FURTHER INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 501,000 SHARES, WITH ACCUMULATED PURCHASE TOTALLING 3,272,500 SHARES
Director's Dealing
2023-06-09 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER SERVIER PRESENTS POSITIVE NEW TIBSOVO (IVOSIDENIB TABLETS) DATA FOR IDH1-MUTATED ACUTE MYELOID LEUKEMIA AT ASCO
Regulatory Filings
2023-06-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023
Share Issue/Capital Change
2023-06-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES NEW DATA ON AYVAKIT (AVAPRITINIB) IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMOR AT ASCO 2023
Regulatory Filings
2023-06-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES ANNOUNCES FDA APPROVAL OF AYVAKIT (AVAPRITINIB) FOR ADULTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS
Regulatory Filings
2023-06-05 English
Monthly Returns
Major Shareholding Notification
2023-06-02 English
(Update) Bonus Issue for the Year Ended 31 December 2022
Share Issue/Capital Change
2023-05-31 English
NOTIFICATION LETTER
Report Publication Announcement
2023-05-31 English
(Update) Special Dividend for the Year Ended 31 December 2022
Notice of Dividend Amount
2023-05-31 English
(Update) Final Dividend for the Year Ended 31 December 2022
Notice of Dividend Amount
2023-05-31 English
Form of Proxy for Use at the 2023 First Class Meeting of the Holders of H Shares to be Held on Friday, 30 June 2023
Proxy Solicitation & Information Statement
2023-05-31 English
NOTICE OF 2023 FIRST CLASS MEETING OF THE HOLDERS OF H SHARES
Proxy Solicitation & Information Statement
2023-05-31 English
Form of Proxy for Use at the Annual General Meeting for the Year Ended 31 December 2022 to be held on Friday, 30 June 2023
AGM Information
2023-05-31 English
NOTICE OF 2022 ANNUAL GENERAL MEETING
AGM Information
2023-05-31 English
CLARIFICATION ANNOUNCEMENT
Regulatory Filings
2023-05-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-05-25 English
Next Day Disclosure Return
Share Issue/Capital Change
2023-05-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-05-17 English
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING OF THE COMPANY BY THE CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR
Director's Dealing
2023-05-17 English
INSIDE INFORMATION ANNOUNCEMENT - CSTONE TO REGAIN DEVELOPMENT AND COMMERCIALIZATION RIGHTS TO SUGEMALIMAB AND NOFAZINLIMAB
Regulatory Filings
2023-05-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023
Regulatory Filings
2023-05-05 English
Monthly Returns
Regulatory Filings
2023-05-05 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-28 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-28 English
(1) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 51% EQUITY INTEREST IN TARGET COMPANIES&#x3b; AND(2) CONTINUING CONNECTED TRANSACTIONS
M&A Activity
2023-04-28 English
RESULTS REPORT FOR THE FIRST QUARTER OF 2023
Interim / Quarterly Report Q1 2023
2023-04-28 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-25 English
FORM OF PROXY FOR ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2023-04-25 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENE
AGM Information
2023-04-25 English
NOTIFICATION LETTER
Report Publication Announcement
2023-04-25 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
Environmental & Social Information
2023-04-25 English
2022 ANNUAL REPORT
Annual Report FY 2022
2023-04-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RELEVANT RULES OF PROCEDURE
Governance Information
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-24 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES FIRST PATIENT ENROLLMENT IN CHINA FOR THE MULTI-REGIONAL PHASE 1 TRIAL OF CS5001, A POTENTIAL BEST-IN-CLASS ROR1-TARGETING ADC
Regulatory Filings
2023-04-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-21 English
ELECTION OF STAFF REPRESENTATIVE DIRECTOR OF THE NINTH SESSION OF THE BOARD ANDELECTION OF STAFF REPRESENTATIVE SUPERVISOR OF THE NINTH SESSION OF THE SUPERVISORY COMMITTE
Board/Management Information
2023-04-19 English
PUBLICATION OF THE OPERATIONAL DATA ANNOUNCEMENT FOR THE FIRST QUARTER OF 2023 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2023-04-19 English
ANNOUNCEMENT ON THE MAJOR OPERATIONAL DATA FOR THE FIRST QUARTER OF 2023
Regulatory Filings
2023-04-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-04-19 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-04-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023
Share Issue/Capital Change
2023-04-11 English
Monthly Returns
Regulatory Filings
2023-04-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES CHINA'S NMPA HAS ACCEPTED THE SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION FOR SUGEMALIMAB AS A FIRST-LINE TREATMENT FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Regulatory Filings
2023-04-06 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PUBLICATION OF GEMSTONE-201 STUDY RESULTS FOR SUGEMALIMAB MONOTHERAPY IN THE TREATMENT OF RELAPSED/REFRACTORY EXTRANODAL NK/T-CELL LYMPHOMA IN JOURN
Regulatory Filings
2023-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report FY 2022
2023-03-27 English
Bonus Issue for the Year Ended 31 December 2022
Share Issue/Capital Change
2023-03-24 English
Special Dividend for the Year Ended 31 December 2022
Notice of Dividend Amount
2023-03-24 English
Final Dividend for the Year Ended 31 December 2022
Notice of Dividend Amount
2023-03-24 English
Annual Report 2022
Annual Report FY 2022
2023-03-24 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report FY 2022
2023-03-24 English
PROPOSED ELECTION OF DIRECTORS OF THE NINTH SESSION OF THE BOARD AND PROPOSED ELECTION OF SUPERVISORS OF THE NINTH SESSION OF THE SUPERVISORY COMMITTEE
Board/Management Information
2023-03-24 English
2022 Environmental, Social and Governance Report
Environmental & Social Information
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
Provision of Financing Guarantee to the Companys Controlled Subsidiaries and Granting of Authorization to Yancoal Australia and Its Subsidiaries to Provide Guarantee for the Daily Operation of the Sub
Capital/Financing Update
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-24 English
(I) GRANT OF RESTRICTED SHARE UNITS UNDER THE POST-IPO RSU SCHEME&#x3b; AND (II) GRANT OF SHARE OPTIONS UNDER THE POST-IPO ESOP
Regulatory Filings
2023-03-23 English
ANNOUNCEMENT ADDING A NEW COMPANY WEBSIT
Regulatory Filings
2023-03-22 English
NOTICE OF 2022 ANNUAL RESULTS PRESENTATION
Investor Presentation
2023-03-22 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES ORAL PRESENTATION OF TRANSLATIONAL DATA FOR CS5001, A POTENTIALLY BEST-IN-CLASS ROR1-TARGETING ADC, AT THE 13TH WORLD ADC LONDON CONFERENCE
Regulatory Filings
2023-03-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-17 English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022
Annual Report FY 2022
2023-03-15 English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings
2023-03-15 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information
2023-03-15 English
TERMS OF REFERENCE OF THE COMPENSATION COMMITTEE
Remuneration Information
2023-03-15 English
VOLUNTARY ANNOUNCEMENT - CSTONE'S PARTNER BLUEPRINT MEDICINES PRESENTS REGISTRATIONAL DATA FROM PIONEER TRIAL OF AYVAKIT (AVAPRITINIB) IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS AT 2023 AAAA
Capital/Financing Update
2023-03-13 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2023-03-12 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-03-10 English
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON MARCH 7, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-03-07 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-03-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023
Share Issue/Capital Change
2023-03-06 English
DATE OF BOARD MEETING
Report Publication Announcement
2023-03-03 English
Monthly Returns
Regulatory Filings
2023-03-01 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCED THE NMPA OF CHINA HAS ACCEPTED THE SUPPLEMENTARY NEW DRUG APPLICATION OF SUGEMALIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC
Regulatory Filings
2023-02-28 English
PUBLICATION OF THE 2022 ANNUAL RESULTS OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Report Publication Announcement
2023-02-27 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCED ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION BY THE EUROPEAN MEDICINES AGENCY FOR SUGEMALIMAB IN METASTATIC SQUAMOUS AND NON-SQUAMOUS NON-SMALL CELL LUNG
Regulatory Filings
2023-02-23 English
DOCUMENTS ON DISPLAY - RULES OF RESTRICTED SHARE AWARD SCHEME
Governance Information
2023-02-20 English
DOCUMENTS ON DISPLAY - RULES OF EMPLOYEE EQUITY PLAN
Capital/Financing Update
2023-02-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-02-20 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change
2023-02-15 English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2023-02-15 English
FORM OF PROXY FOR EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement
2023-02-14 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2023-02-14 English
(1) PROPOSED RE-GRANTS OF SHARE OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP&#x3b; (2) PROPOSED GRANT OF SHARE OPTIONS TO A DIRECTOR AND CHIEF EXECUTIVE OFFICER UNDER THE POST-IPO ESOP&#x3b; (
Proxy Solicitation & Information Statement
2023-02-14 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCED PRECISION MEDICINE AVAPRITINIB (AYVAKIT) RECOMMENDED IN CHINA'S FIRST "CHINESE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF SYSTEMIC MASTOCYTOSIS I
Regulatory Filings
2023-02-14 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2023-02-07 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023
Regulatory Filings
2023-02-06 English
(REVISED) MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings
2023-02-06 English
POSITIVE PROFIT ALERT
Regulatory Filings
2023-02-02 English
Monthly Returns
Share Issue/Capital Change
2023-02-02 English
POSITIVE PROFIT ALERT FOR THE YEAR OF 2022
Earnings Release FY 2022
2023-01-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-01-20 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA FOR THE FOURTH QUARTER OF 2022
Capital/Financing Update
2023-01-19 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-01-19 English
PUBLICATION OF THE OPERATIONAL DATA ANNOUNCEMENT FOR THE FOURTH QUARTER OF 2022 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANKUANG ENERGY GROUP COMPANY LIMITED
Regulatory Filings
2023-01-19 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2023-01-18 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE OF COMPOSITION OF THE NOMINATION COMMITTEE, AND CHANGE OF JOINT COMPANY SECRETARY AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LIS
Board/Management Information
2023-01-18 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES THE NDA APPROVAL OF GAVRETO (PRALSETINIB) FOR THE TREATMENT OF ADVANCED RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER AND RET-ALTERED THYROID CANCER IN TAIWA
Regulatory Filings
2023-01-17 English
(I) PROPOSED CANCELLATION AND RE-GRANTS OF OPTIONS TO EXISTING GRANTEES UNDER THE POST-IPO ESOP&#x3b; AND (II) PROPOSED AMENDMENTS TO THE SHARE INCENTIVE SCHEMES
Capital/Financing Update
2023-01-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings
2023-01-06 English
Monthly Returns
Regulatory Filings
2023-01-03 English
INSIDE INFORMATION ANNOUNCEMENT - CSTONE ANNOUNCED THE REGISTRATIONAL CLINICAL TRIAL OF SUGEMALIMAB AS FIRST-LINE TREATMENT IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA MET PRIMARY ENDPOINTS AN
Regulatory Filings
2023-01-03 English